Report: More than half of the world's population will be overweight/obese by 2035

Published Date: 08 Mar 2023

The World Health Organization's 2023 Atlas predicts that 51% of the world's population, or more than 4 billion people, will be overweight or obese within the next 12 years.

Read Full News

Latest News

UnitedHealth Flags Challenges in Medicare Obesity Drug Pilot

UnitedHealth said on Tuesday there are "challenges" around the Medicare pilot program to cover obesity drugs, ⁠adding uncertainty over whether health insurers would sign up...

More Teens Try to Lose Weight — Few See Real Results

Weight-loss attempts increase over two decades among US adolescents, but clinically meaningful weight loss remains uncommon despite widespread efforts.

Delay in Medicare Pilot for Obesity Drugs May Not Hurt Near-term Demand, Analysts Say

A delay in a Medicare pilot to cover obesity drugs due to health insurers' hesitation to participate in the program is unlikely to ⁠dent near-term demand for weight-loss...

Childhood ‘Adiposity Rebound’ Challenged as BMI ‘Fallacy’

A widely accepted marker of early obesity risk may instead reflect normal muscle development, with implications for how clinicians assess adiposity in children.

Hims & Hers Says It Has Steady Estrogen Patch Supply Amid US Shortages

Use ‌of estrogen patches rose after the FDA removed a longstanding safety warning and promoted hormone replacement therapy for some patients.

Sleep Apnea in Women Often Missed After Menopause

Sleep apnea in women may increase after menopause, yet atypical symptoms and low clinical suspicion delay diagnosis in routine practice.

Todays Updates

US to Loosen Marijuana Rules in Major Shift for $47 Billion Industry

The U.S. Department of Justice said on Thursday it would immediately loosen restrictions on some marijuana products and move quickly to reclassify the drug as less...

ICIs Show High Responses in Mediastinal B-Cell Lymphoma

Pembrolizumab and nivolumab show favorable response rates with or without consolidation therapy.

EMA Recommends Generic in Advanced/Metastatic Breast Cancer

Palbociclib slows cancer cell proliferation in patients with HR+/HER2- locally advanced or metastatic breast cancer.

Todays Updates

US to Loosen Marijuana Rules in Major Shift for $47 Billion Industry

The U.S. Department of Justice said on Thursday it would immediately loosen restrictions on some marijuana products and move quickly to reclassify the drug as less...

ICIs Show High Responses in Mediastinal B-Cell Lymphoma

Pembrolizumab and nivolumab show favorable response rates with or without consolidation therapy.

EMA Recommends Generic in Advanced/Metastatic Breast Cancer

Palbociclib slows cancer cell proliferation in patients with HR+/HER2- locally advanced or metastatic breast cancer.

Latest News

UnitedHealth said on Tuesday there are "challenges" around the Medicare pilot program to cover obesity drugs, ⁠adding uncertainty over whether health insurers would sign up...

Weight-loss attempts increase over two decades among US adolescents, but clinically meaningful weight loss remains uncommon despite widespread efforts.

A delay in a Medicare pilot to cover obesity drugs due to health insurers' hesitation to participate in the program is unlikely to ⁠dent near-term demand for weight-loss...

A widely accepted marker of early obesity risk may instead reflect normal muscle development, with implications for how clinicians assess adiposity in children.

Use ‌of estrogen patches rose after the FDA removed a longstanding safety warning and promoted hormone replacement therapy for some patients.

Sleep apnea in women may increase after menopause, yet atypical symptoms and low clinical suspicion delay diagnosis in routine practice.

News All Time

PCOS Linked to Later Menopause and Fewer Symptoms

A population-based study reveals that women with PCOS are less likely to reach late perimenopause or postmenopause by their mid-40s than their peers and experience fewer menopausal symptoms.

Thyroid Dysfunction Tied to NAFLD in Children With Obesity

Elevated levels of thyroid-stimulating hormone may signal the presence of non-alcoholic fatty liver disease in children and adolescents with obesity, according to a meta-analysis of 10 studies.

Why Constipation Remains Underrecognized in Pregnancy

Hormonal changes, reduced motility, and mechanical factors drive constipation during pregnancy, which requires targeted assessment and safe management.

Lilly CEO Sees Weight-loss Drugs Reaching About Half Of Potential Users At Peak

Weight-loss drugs may eventually reach only about 50% of the overweight and obese people who could benefit from them due to complexities of healthcare systems ⁠and financial...

Restrictive Food Disorder Prevalence Overestimated

Avoidant/restrictive food intake disorder was inconsistently identified in patients with GI disorders, likely leading to overestimation of its prevalence.

M1 Variant Lowers APOL1 Kidney Disease Risk

Although APOL1 variants are linked to kidney disease risk, the presence of the M1 genetic variant appears to reduce that risk.

‘Secret Shopper’ Study Finds Risks in Compounded GLP-1s

Study on compounded GLP-1s uncovers use of additives and questionable sterility practices, revealing legally ‘murky’ area.

Weekend Catch-Up Sleep May Harm Glucose Control

A large NHANES analysis suggests that 7 hours of sleep may represent a metabolic sweet spot, whereas too little, too much, or excessive weekend catch-up sleep may worsen insulin resistance.

Updated AACE Algorithms Guide Type 2 Diabetes Management

New graphics and text address prediabetes, T2D, and management of cardiovascular risk factors.

Microbiome May Predict Fiber-Induced Bloating

Few patients with bloating experience symptoms from fermentable fibers, with predictors including a higher baseline symptom burden and distinct gut microbiome patterns.

Ontario Action Plan Aims to Increase Access to Primary Care

The provincial government is entering a physician services agreement with the goal of attracting and retaining more family doctors.

Intensive Lifestyle Intervention Boosts QOL in Obesity

Greater weight loss during a 24-month primary care lifestyle intervention was associated with larger improvements in quality-of-life among patients with obesity.

Upcoming AACE Meeting Theme in Las Vegas: ‘Viva Nutrition!’

The American Association of Clinical Endocrinology (AACE) Annual Meeting 2026 will also feature topics such as AI, preventing type 1 diabetes, and thyroid disease management.

Lilly's Obesity Pill Draws 1,390 US Prescriptions in Launch Week

Eli Lilly's newly launched weight-loss pill was prescribed 1,390 times in the U.S. in its first week of sales, according to analysts who cited IQVIA data, ⁠indicating that...

Meal Patterns Matter for Better Sleep and Quality of Life

More frequent and irregular meals are linked to poor sleep and lower quality of life, and a longer interval between the last meal and bedtime may improve sleep quality and mental and physical health.

Rise of Early Onset Diabetes a Looming Crisis

More and more patients are developing type 2 diabetes while still young. The diagnosis may lead to a life of disease.

Recommended News For You

Unlocking the secrets of the fibrotic fortress that surrounds and protects pancreatic cancer

Why alarm is easing over a rise in pancreatic cancer among the young

Mental health risk persists years after cancer diagnosis

Underprescribed for Alcohol Use Disorder is pharmacotherapy.

Report: High risk of lung cancer from respirable crystalline silica even below the current occupational exposure limit

Momelotinib, a JAK inhibitor, has FDA approval to treat adult myelofibrosis in anemic patients.

In early dementia, SSRIs enhance cognition and major depression.

Recommended Articles For You

The latest research on Iron Binding Capacity: The Little-Known Factor That Could Impact Your Health v 

Radiation Oncology Advances: Guidelines, Trials, Digital Tools & Education 

Liquid Biopsy in SCLC: cfDNA Profiling for Diagnosis and Treatment Monitoring 

First-Line Immuno-Hematology Examinations: Essential Diagnostic Tools for Patient Care 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

After two years, a significant left nasal obstruction was finally diagnosed.

2.

In Higher-Risk MDS, CMML, All-Oral Therapy Has Promise.

3.

In R/R Follicular Lymphoma, Tisa-Cel Produces Long-Lasting Responses.

4.

AI could help improve early detection of interval breast cancers

5.

Older Adults With Advanced Cancer Prioritize Quality of Life

1.

Managing Hematoma: A Guide to Prevention and Treatment

2.

Autophagy: A Double-Edged Sword in Cancer Development, Immune Evasion, and Drug Resistance

3.

A Breakthrough in Multiple Myeloma: Darzalex Delays Disease Progression by 51%

4.

Breaking Down the Different Types of Lymphoma: What You Need to Know 

5.

Prognostic Role of PLAU in Pan-Cancer and Neutrophil Infiltration in Bladder Cancer

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VIII

2.

CNS Clarity from Day One: Rethinking Early Diagnostic Strategies in ALK+NSCLC

3.

Current Scenario of Cancer- Palliative Care to Close the Care Gap

4.

Cost Burden/ Burden of Hospitalization For R/R ALL Patients

5.

Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part IV

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot